Healthcare entity
All 2 tracked stories fall under one category: market-trends. India is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. The 18-day window averages about 0.8 stories each week. They are less corroborated than the beat average, carrying 3 original sources each against 5.1 for the same window.
Last mentioned: Jul 28, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 2 tracked stories fall under one category: market-trends. India is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. The 18-day window averages about 0.8 stories each week. They are less corroborated than the beat average, carrying 3 original sources each against 5.1 for the same window. At 5.5, the average consequence score sits below the same-window beat average of 6.5. We currently track 2 Healthcare stories that mention Waiel Awwad, published between July 11, 2026 and July 28, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 151 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Waiel Awwad. Shared-story counts are live from our verified record — not editorial picks.
Post-war Sudan is targeting Indian healthcare investment to rebuild hospitals, supply chains, and pharmaceutical access, with Indian medicines already dominating imports. A high-level roundtable signals government support and regulatory engagement.
Sudan's appeal for Indian healthcare investment beyond pharma offers a vast opportunity for health IT, medical devices, and hospital infrastructure, underscored by India's 51% share of medicine imports. The roundtable signals a shift from aid to commercial partnership in rebuilding a war-torn health system.
Waiel Awwad is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
